Avid Bioservices Inc

NASDAQ: CDMO    
Share price (5/17/24): $9.12    
Market cap (5/17/24): $579 million
Search in Documents
Key Exhibits
External Links
7 Avid Bioservices Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.1
from 8-K 3 pages First Amendment to the Avid Bioservices, Inc. Deferred Compensation Plan
12/34/56
EX-10.2
from 8-K 6 pages Form of Notice of Grant of Performance Stock Unit Award Avid Bioservices, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-10.1
from 8-K 16 pages Avid Bioservices, Inc. Deferred Compensation Plan Preamble
12/34/56
EX-10.1
from 8-K 11 pages Avid Bioservices, Inc. Executive Severance Plan
12/34/56
EX-10.1
from 8-K 6 pages Form of Notice of Grant of Performance Stock Unit Award Avid Bioservices, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-10.1
from 10-Q 1 page First Amendment to the Avid Bioservices, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-10.1
from 8-K 5 pages Form of Notice of Grant of Performance Stock Unit Award Avid Bioservices, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-10.1
from 8-K 28 pages To: Avid Bioservices, Inc. 2642 Michelle Drive, Suite 200 Tustin, California 92780 Attention: [ ] Telephone No.: [ ] Facsimile No.: [ ] Re: [Base][additional] Call Option Transaction
12/34/56
EX-10.8
from 10-Q 13 pages Employment Agreement
12/34/56
EX-10.7
from 10-K 12 pages Employment Agreement
12/34/56
EX-10.6
from 10-K 6 pages Separation Agreement and Release of All Claims
12/34/56
EX-10.11
from 10-K 26 pages Asset Assignment and Purchase Agreement
12/34/56
EX-10.2
from 10-Q 5 pages Severance Agreement and Mutual Release of All Claims
12/34/56
EX-10.1
from 8-K 19 pages Settlement Agreement
12/34/56
EX-10.28
from 8-K 10 pages Peregrine Pharmaceuticals, Inc. Common Stock Purchase Agreement 18,518,518 Shares of Common Stock October 30, 2015 Common Stock Purchase Agreement
12/34/56
EX-10.27
from 8-K 42 pages Peregrine Pharmaceuticals, Inc. $20,000,000 Common Stock Equity Distribution Agreement
12/34/56
EX-10.26
from 8-K 38 pages Peregrine Pharmaceuticals, Inc. Common Stock (Par Value $0.001 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-10.27
from 8-K 2 pages Amendment No. 1 to at Market Issuance Sales Agreement
12/34/56
EX-10.29
from 8-K 38 pages Peregrine Pharmaceuticals, Inc. Common Stock (Par Value $0.001 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-10.28
from 8-K 38 pages Peregrine Pharmaceuticals, Inc. 10.50% Series E Convertible Preferred Stock (Liquidation Preference $25.00 Per Share) at Market Issuance Sales Agreement
12/34/56